Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Coghill

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
Developmental Medicine and Child Neurology|September 15, 2022
Preterm postnatal complications and risk of attention-deficit/hyperactivity disorderWinnie Wan-Yee Tso, Frederick Ka Wing Ho, David Coghill, et al.
The Australian and New Zealand Journal of Psychiatry|May 30, 2020
The value of early intervention in creating the new mental health system: Response to Allison et alAndrew Chanen, Alison Yung, Eoin Killackey, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|July 16, 2008
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications]Tobias Banaschewski, David Coghill, Paramala Santosh, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|July 16, 2008
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations]Tobias Banaschewski, David Coghill, Paramala Santosh, et al.
European Child & Adolescent Psychiatry|May 9, 2006
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelineTobias Banaschewski, David Coghill, Paramala Santosh, et al.
BMJ (Clinical Research Ed.)|June 2, 2017
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort studyKenneth K C Man, Esther W Chan, Patrick Ip, et al.
Molecular Psychiatry|April 22, 2018
Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescentsXinyu Zhou, Lanxiang Liu, Xinghui Lan, et al.
Neuroscience and Biobehavioral Reviews|December 17, 2017
Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysisKenneth K C Man, Esther W Chan, Patrick Ip, et al.
European Child & Adolescent Psychiatry|March 20, 2013
An inventory of European data sources for the long-term safety evaluation of methylphenidateMacey L Murray, Suppachai Insuk, Tobias Banaschewski, et al.
European Child & Adolescent Psychiatry|June 4, 2015
A comprehensive scoping review of ability and disability in ADHD using the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY)Elles de Schipper, Aiko Lundequist, Anna Löfgren Wilteus, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
Developmental Medicine and Child Neurology|September 15, 2022
Preterm postnatal complications and risk of attention-deficit/hyperactivity disorderWinnie Wan-Yee Tso, Frederick Ka Wing Ho, David Coghill, et al.
The Australian and New Zealand Journal of Psychiatry|May 30, 2020
The value of early intervention in creating the new mental health system: Response to Allison et alAndrew Chanen, Alison Yung, Eoin Killackey, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|July 16, 2008
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications]Tobias Banaschewski, David Coghill, Paramala Santosh, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|July 16, 2008
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations]Tobias Banaschewski, David Coghill, Paramala Santosh, et al.
European Child & Adolescent Psychiatry|May 9, 2006
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelineTobias Banaschewski, David Coghill, Paramala Santosh, et al.
BMJ (Clinical Research Ed.)|June 2, 2017
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort studyKenneth K C Man, Esther W Chan, Patrick Ip, et al.
Molecular Psychiatry|April 22, 2018
Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescentsXinyu Zhou, Lanxiang Liu, Xinghui Lan, et al.
Neuroscience and Biobehavioral Reviews|December 17, 2017
Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysisKenneth K C Man, Esther W Chan, Patrick Ip, et al.
European Child & Adolescent Psychiatry|March 20, 2013
An inventory of European data sources for the long-term safety evaluation of methylphenidateMacey L Murray, Suppachai Insuk, Tobias Banaschewski, et al.
European Child & Adolescent Psychiatry|June 4, 2015
A comprehensive scoping review of ability and disability in ADHD using the International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY)Elles de Schipper, Aiko Lundequist, Anna Löfgren Wilteus, et al.
Pageof 23